cellarity

Cellarity

Cellarity, a flagship pioneering company, sets itself apart through their unique perspective. Cellarity has the ambition to discover drugs for diseases by looking into the cellular level, instead of the macro level.

By targeting the cellular and molecular components of health issues, along with high-tech computational and biological devices, Cellarity can find newer and more detailed solutions.

Learn more and stay up to date about Cellarity through the links below.

Modelling Biology: A Q&A with Cellarity’s CSO

/

Company to Watch – Cellarity In the final article in the Company to Watch series on Cellarity, Big4Bio editor Marie Daghlian spoke with Chief Scientific Officer Laurens Kruidenier about what impressed him about the company, what he sees as the strength of the Cellarity platform and how it works, and why we should keep our […]

Read More

Podcast: Transforming Drug Discovery by Focusing on Cell Behavior

/

Companies to Watch – Cellarity The Big4Bio Podcast · Transforming Drug Discovery by Focusing on Cell Behavior   Fabrice Chouraqui, CEO of Cellarity, speaks about the company’s approach to drug discovery, the technology it is harnessing, and why focusing on cells rather than molecular targets are a better way to discover drugs.     This […]

Read More

A Platform to Uncover Biological Complexity to Target Virtually Any Disease

/

Company to Watch – Cellarity In the second of four features on Cellarity, Big4Bio spoke with CEO Fabrice Chouraqui about the company’s unique platform, initial pipeline, and plans moving forward. by Marie Daghlian Cellarity aims to discover medicines that can resolve human disease, potentially any disease. To do this it has developed a cell-centric platform […]

Read More

The Big4Bio Company to Watch Program
March 2022: Cellarity

/

  THE COMPANY A Cell Centric Drug Discovery Platform to Transform Therapeutic Development How Cellarity is uncovering the complexity of human biology and changing the paradigm of classic drug discovery to bring new treatments to patients.   THE TECHNOLOGY, PART 1 A Platform to Uncover Biological Complexity to Target Virtually Any Disease More about the […]

Read More